Outcomes of surgical treatment for isolated adrenal metastasis from non-small cell lung cancer

被引:4
作者
Buero, Agustin [1 ]
Nardi, Walter S. [2 ]
Chimondeguy, Domingo J. [1 ,3 ]
Pankl, Leonardo G. [1 ]
Lyons, Gustavo A. [1 ]
Arboit, David Gonzalez [3 ]
Quildrian, Sergio [2 ]
机构
[1] Buenos Aires British Hosp, Thorac Surg Dept, Perdriel 74,C1280AEB, Buenos Aires, DF, Argentina
[2] Buenos Aires British Hosp, Dept Gen Surg, Retroperitoneal Pelv & Adrenal Unit, Perdriel 74,C1280AEB, Buenos Aires, DF, Argentina
[3] Austral Univ Hosp, Thorac Surg Dept, Av Juan Domingo Peron 1500,B1629AHJ, Buenos Aires, DF, Argentina
来源
ECANCERMEDICALSCIENCE | 2021年 / 15卷
关键词
non-small cell lung cancer; oligometastasis; adrenal metastasis; adrenalectomy; RESECTION; SURVIVAL; MASSES;
D O I
10.3332/ecancer.2021.1322
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Long-term survival of patients who undergo surgical resection of isolated adrenal metastasis instead of nonsurgical treatment has shown higher values than those described for stage IVA. The primary endpoint was to evaluate overall survival (OS) of patients with single adrenal metastasis from non-small cell lung cancer (NSCLC), who underwent surgical treatment. The secondary endpoint was to evaluate and compare the OS and disease-free survival (DFS) according to: pathological lung tumour size, histology, lymph node involvement, type of metastasis at the time of diagnosis and laterality of the metastasis according to the primary lung tumour. Methods: From August 2007 to March 2020, 13 patients with isolated adrenal gland metastasis were identified. We performed a descriptive observational study including patients with diagnosed single adrenal gland metastasis of resectable primary lung cancer and no history of other malignant disease. Clinical data obtained included patient demographics, metastases characteristics, laterality of the metastasis, time between surgeries, length of follow-up, survival status, pathological lung tumour size, histology and lymph node involvement. The variables analysed were OS and DFS. Results: Median global OS was 31.9 months (interquartile range (IQR), 19.1-51.4). The 2- and 5-year OS estimated was 54% (95% CI: 29.5%-77.4%) and 36% (95% CI: 13.4%-68.1%), respectively. In patients with NSCLC without mediastinal lymph node involvement, we obtain a median OS of 40 months (IQR, 27.4-51.4) and a 2- and 5-year OS estimated of 75% (95% CI: 43.2%-92.2%) and 50% (95% CI: 18.7%-81.2%), respectively. Recurrence was detected in five patients with a median DFS of 11.9 months (IQR, 6-34.2). Conclusion: The resection of the adrenal metastasis should be considered if the primary lung cancer is resectable. Presence of mediastinal lymph node involvement should be ruled out through invasive staging of the mediastinum before performing adrenal and lung surgery. Proper selection of patients who would benefit from surgery is essential to obtain better survival results.
引用
收藏
页数:8
相关论文
共 21 条
[1]   SURVIVAL DETERMINANTS IN EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER - THE SOUTHWEST-ONCOLOGY-GROUP EXPERIENCE [J].
ALBAIN, KS ;
CROWLEY, JJ ;
LEBLANC, M ;
LIVINGSTON, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) :1618-1626
[2]   Oligometastatic non-small cell lung cancer (NSCLC): adrenal metastases. Experience in a single institution [J].
Barone M. ;
Di Nuzzo D. ;
Cipollone G. ;
Camplese P. ;
Mucilli F. .
Updates in Surgery, 2015, 67 (4) :383-387
[3]   Lung cancer surgery in oligometastatic patients: outcome and survival [J].
Casiraghi, Monica ;
Bertolaccini, Luca ;
Sedda, Giulia ;
Petrella, Francesco ;
Galetta, Domenico ;
Guarize, Juliana ;
Maisonneuve, Patrick ;
De Marinis, Filippo ;
Spaggiari, Lorenzo .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 57 (06) :1173-1180
[4]   Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report [J].
Dingemans, Anne-Marie C. ;
Hendriks, Lizza E. L. ;
Berghmans, Thierry ;
Levy, Antonin ;
Hasan, Baktiar ;
Faivre-Finn, Corinne ;
Giaj-Levra, Matteo ;
Giaj-Levra, Niccolo ;
Girard, Nicolas ;
Greillier, Laurent ;
Lantuejoul, Sylvie ;
Edwards, John ;
O'Brien, Mary ;
Reck, Martin ;
Smit, Egbert F. ;
Van Schil, Paul ;
Postmus, Pieter E. ;
Ramella, Sara ;
Lievens, Yolande ;
Gaga, Mina ;
Peled, Nir ;
Scagliotti, Giorgio, V ;
Senan, Suresh ;
Paz-Ares, Luiz ;
Guckenberger, Matthias ;
McDonald, Fiona ;
Ekman, Simon ;
Cufer, Tanja ;
Gietema, Hester ;
Infante, Maurizio ;
Dziadziuszko, Rafal ;
Peters, Solange ;
Porta, Ramon Rami ;
Vansteenkiste, Johan ;
Dooms, Christophe ;
de Ruysscher, Dirk ;
Besse, Benjamin ;
Novello, Silvia .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) :2109-2119
[5]   A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis [J].
Downey, RJ ;
Ng, KK ;
Kris, MG ;
Bains, MS ;
Miller, VA ;
Heelan, R ;
Bilsky, M ;
Ginsberg, R ;
Rusch, VW .
LUNG CANCER, 2002, 38 (02) :193-197
[6]   PROSPECTIVE EVALUATION OF UNILATERAL ADRENAL MASSES IN PATIENTS WITH OPERABLE NON-SMALL-CELL LUNG-CANCER [J].
ETTINGHAUSEN, SE ;
BURT, ME .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) :1462-1466
[7]   The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer [J].
Goldstraw, Peter ;
Chansky, Kari ;
Crowley, John ;
Rami-Porta, Ramon ;
Asamura, Hisao ;
Eberhardt, Wilfried E. E. ;
Nicholson, Andrew G. ;
Groome, Patti ;
Mitchell, Alan ;
Bolejack, Vanessa .
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (01) :39-51
[8]   Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study [J].
Gomez, Daniel R. ;
Blumenschein, George R., Jr. ;
Lee, J. Jack ;
Hernandez, Mike ;
Ye, Rong ;
Camidge, D. Ross ;
Doebele, Robert C. ;
Skoulidis, Ferdinandos ;
Gaspar, Laurie E. ;
Gibbons, Don L. ;
Karam, Jose A. ;
Kavanagh, Brian D. ;
Tang, Chad ;
Komaki, Ritsuko ;
Louie, Alexander V. ;
Palma, David A. ;
Tsao, Anne S. ;
Sepesi, Boris ;
William, William N. ;
Zhang, Jianjun ;
Shi, Qiuling ;
Wang, Xin Shelley ;
Swisher, Stephen G. ;
Heymach, John V. .
LANCET ONCOLOGY, 2016, 17 (12) :1672-1682
[9]   OLIGOMETASTASES [J].
HELLMAN, S ;
WEICHSELBAUM, RR .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :8-10
[10]   Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer A Phase 2 Randomized Clinical Trial [J].
Iyengar, Puneeth ;
Wardak, Zabi ;
Gerber, David E. ;
Tumati, Vasu ;
Ahn, Chul ;
Hughes, Randall S. ;
Dowell, Jonathan E. ;
Cheedella, Naga ;
Nedzi, Lucien ;
Westover, Kenneth D. ;
Pulipparacharuvil, Suprabha ;
Choy, Hak ;
Timmerman, Robert D. .
JAMA ONCOLOGY, 2018, 4 (01)